BFRI

Healthcare Drug Manufacturers - Specialty & Generic

Biofrontera Inc.

$1.01

-0.03 -2.40% today

Price History

Not enough data

Key Stats

Market Cap

15.08M

Avg Volume

561,223

EPS

-$0.43

52W High

$1.66

52W Low

$0.56

Div. Yield

0.0%

Analyst Ratings

Buy

Str Buy

Buy

Hold

Sell

Str Sell

Valuation

Forward P/E

2.36

P/B Ratio

2.42

P/S Ratio

0.33

EV/EBITDA

-3.00

EV/Revenue

0.39

Margins

Gross Margin 79.3%

Operating Margin (4.4%)

Net Margin (13.8%)

EBITDA Margin (12.9%)

Growth & Returns

Revenue Growth (YoY)

32.9%

Return on Equity

(988.4%)

Return on Assets

(17.4%)

Liquidity & Leverage

Current Ratio

1.18

Quick Ratio

1.00

Debt / Equity

1.26

Total Cash

4.67M

Total Debt

7.50M

About

Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.